EFTUD2 is a promising diagnostic and prognostic indicator involved in the tumor immune microenvironment and glycolysis of lung adenocarcinoma
EFTUD2 is a potential diagnostic and prognostic marker for LUAD, associated with immune infiltration, the tumor microenvironment, the cGAS-STING pathway, m6A modification, and glycolysis.
Authors
- Lu Han (ORCID: https://orcid.org/0000-0003-4688-0907)
- Xiyang Su (ORCID: https://orcid.org/0000-0001-9412-997X)
- Zebin Zhang (ORCID: https://orcid.org/0000-0002-9828-4245)
- Ankang Yin (ORCID: https://orcid.org/0000-0002-1933-601X)
- Juan Wang
- Wei Wang (ORCID: https://orcid.org/0009-0003-7539-9394)
- Yi Chen (ORCID: https://orcid.org/0000-0002-2181-0403)
- Yufan Xu
- Guoxiang Fu (ORCID: https://orcid.org/0000-0003-4751-1222)
- Runan Wang (ORCID: https://orcid.org/0000-0001-9245-6096)
Institutions
- Zhejiang Chinese Medical University (CN)
- Sir Run Run Shaw Hospital (CN)
- Tongde Hospital of Zhejiang Province (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.3389/fonc.2025.1499217
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00